On Health Policy Archives

NCHR Testimony to FDA Regarding Suicide and the Use of Antidepressants by Children

September 13, 2004. The widespread use of antidepressant drugs by children and youth in the United States is cause for great concern.

NCHR Testimony at the Institute of Medicine on Review of the WIC Food Packages

September 9, 2004. The WIC program provides essential help to our most vulnerable children and mothers, and the need for this vital program continues to grow.

Statement on the FDA/EPA Dietary Advisory on Methylmercury in Fish

March 19, 2004. By any standard, FDA’s current efforts at protecting the American public from the health risks of mercury in fish do not do enough to protect the public or to educate them so that they can protect themselves.

Testimony at FDA Food Advisory Committee on Methylmercury

December 11, 2003. According to information provided to this Advisory Committee yesterday by Dr. Carrington and Dr. Bolger, the proposed limit of 12 oz. of fish per week would not significantly decrease consumers’ current exposure to methylmercury.

Comment On Medwatch: The FDA Medical Products Reporting Program

April 23, 2003. Rather than weaken or dismantling the MedWatch system, the FDA should borrow ideas from more rigorous systems in other countries. The FDA should provide ongoing education and incentives for quality reporting by both health professionals and consumers.